China: New epidemic prevention and control measures further ease China-bound travel requirements

In brief

On 11 November 2022, mainland China announced new measures for COVID-19 prevention and control, with slightly more relaxed policies in terms of identifying and managing close contacts, classification of high-risk areas, COVID-19 testing and quarantine measures. The new measures further ease requirements for inbound international travel by simplifying pre-departure testing requirements and reducing quarantine time after arrival in China.


Key takeaways

The Comprehensive Team for Joint Prevention and Control Mechanisms for COVID-19 under the State Council of the People's Republic of China announced 20 new measures on 11 November 2022 to reduce economic and social disruptions while maintaining strong epidemic prevention and control. One of the key adjustments is to ease requirements for inbound international travel.

Following the announcement, the Chinese embassies and consulates have adjusted pre-departure testing and HDC-code application requirements for China-bound travelers, as follows:

  • Travelers will only be required to perform one nucleic acid test within 48 hours before their flight. Those who test negative shall continue to apply for an HDC-code through the in-charge Chinese embassies and consulates.
  • Travelers taking transit flights through a third country may opt to take the nucleic acid test and apply for the HDC-code either in the departure country or in the transit country. They only need to ensure that their green health code is within its validity period when they board the China-bound flight in the transit country.
  • Additional restrictions such as health observation and reporting requirements for travelers who have a history of COVID-19 infection or are close contacts of someone with COVID-19 have been removed.

In addition to the new testing policies for China-bound travelers, the new measures have removed the "circuit breaker" mechanism, under which China-bound flights were cancelled if an airline was found to carry a certain number of passengers who tested positive for COVID-19, in order to facilitate international travel.

The centralized quarantine period for China-bound travelers has been reduced from seven days to five days, followed by another three days of home-based health status monitoring (though if an international traveler has no place of residence in China, they may have to spend all eight days in a designated quarantine hotel).

In terms of local prevention measures, China has reclassified risk areas to be high or low risk only, meaning that the medium-risk category has been removed to reduce domestic travel restrictions. It will no longer track secondary close contacts of persons who test positive for COVID-19. The same quarantine timeframe (i.e., five + three days) for China-bound travelers also applies to close contacts of COVID-19 positive cases within China.

Overall, the new measures further reduce international and domestic travel restrictions. Nevertheless, multiple-entry business visas and tourist visas, which are desired by many international travelers, have not been resumed. Passport applications for Chinese citizens are still strictly limited to those with essential outbound travel needs, such as work, business, study and emergency family matters.

* * * * *

Zora Mao is an associate in FenXun Partners. FenXun established a Joint Operation Office with Baker McKenzie in China as Baker McKenzie FenXun, which was approved by the Shanghai Justice Bureau in 2015.


LOGO BM-FenXun bold-RGB (003)

Baker & McKenzie FenXun (FTZ) Joint Operation Office is a joint operation between Baker & McKenzie LLP, an Illinois limited liability partnership, and FenXun Partners, a Chinese law firm. The Joint Operation has been approved by the Shanghai Justice Bureau. In accordance with the common terminology used in professional service organisations, reference to a "partner" means a person who is a partner, or equivalent, in such a law firm.  This may qualify as “Attorney Advertising” requiring notice in some jurisdictions.  Prior results do not guarantee a similar outcome.

This client alert has been prepared for clients and professional associates of Baker & McKenzie FenXun (FTZ) Joint Operation Office. Whilst every effort has been made to ensure accuracy, this client alert is not an exhaustive treatment of the area of law discussed and no responsibility for any loss occasioned to any person acting or refraining from action as a result of material in this presentation is accepted by Baker & McKenzie FenXun (FTZ) Joint Operation Office.

Contact Information
Jonathan Isaacs
Registered Foreign Lawyer at BakerMcKenzie
Hong Kong
Read my Bio

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.